Virtus ETF Advisers LLC Tango Therapeutics, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 24,945 shares of TNGX stock, worth $48,642. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,945
Previous 10,984
127.1%
Holding current value
$48,642
Previous $84,000
8.33%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding TNGX
# of Institutions
138Shares Held
91.1MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$32.9 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$20.9 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$20.7 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$10.8 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$7.8 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $172M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...